Related Experiment Video

Updated: Feb 10, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K

Humoral Immunity in Heart Failure

Amrita Sarkar1, Khadija Rafiq1

  • 1Center for Translational Medicine, Thomas Jefferson University, St, Philadelphia, PA 19107, United States.

Cardiovascular & Hematological Disorders Drug Targets
|May 19, 2018
PubMed

Insights

Inflammation, particularly involving B-cells and immune system imbalances, significantly contributes to heart failure (HF) development. Understanding these immune roles is crucial for developing new therapeutic targets to combat cardiovascular disease (CVD).

Area of Science:

  • Immunology
  • Cardiology
  • Pathophysiology

Background:

  • Cardiovascular disease (CVD), encompassing conditions like hypertension and coronary heart disease, remains a leading global cause of mortality, often culminating in heart failure (HF).
  • Inflammation is increasingly recognized as a key player in the pathogenesis of heart failure, stemming from an imbalance in pro-inflammatory and anti-inflammatory cytokines.
  • Cardiac inflammation is a central pathophysiological mechanism in failing hearts, irrespective of the underlying cause of HF.

Purpose of the Study:

  • To review the specific role of B-cells within the humoral immune system in the context of heart failure.
  • To highlight the urgent need for novel therapeutic targets and advanced strategies for combating heart failure.
  • To underscore the importance of understanding humoral immunity in identifying potential new treatment avenues for HF.

Main Methods:

  • Literature review of experimental and clinical studies.
  • Analysis of the role of immune system disturbances in heart failure.
  • Focus on the specific contributions of B-cells and cytokine imbalances.

Main Results:

  • Cardiac inflammation, driven by immune system dysregulation, is a significant factor in heart failure.
  • B-cells play a distinct role in the pathophysiology of heart failure states.
  • Imbalances in pro- and anti-inflammatory cytokines are linked to the inflammatory processes in HF.

Conclusions:

  • Understanding the function of humoral immunity, especially B-cells, is essential for developing novel therapeutic strategies against heart failure.
  • Targeting immune system components may offer promising new treatment avenues for cardiovascular disease and heart failure.
  • Further research into the immune mechanisms of HF is critical for advancing treatment options.

Keywords:
B-cellInflammationcardiovascular diseaseheart failurehumoral immunitymyocardium.

More Related Videos

Isolation and Identification of Extravascular Immune Cells of the Heart08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

14.0K
Gene Transfer for Ischemic Heart Failure in a Preclinical Model07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

13.4K

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
84.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
993
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.9K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
947
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
391
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K